StockData
IQVIA Holdings Inc. logo

IQVIA Holdings Inc. (IQV) stock

IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 27, 2026Score 8/3020% above fair value
$267.33−7.73 (-2.81%)

Close on Oct 30, 2026Market cap $44.00BP/E 33.2Yield –

Earnings

Iqvia's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 4, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$4.43B
+8.0% on a year earlier
Adjusted Diluted Earnings per Share, Q3 FY2026
$3.34
$3.00 a year earlier
Latest guidance
Issued
Oct 27, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of Iqvia's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 4, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Oct 27, 2026before the open$4.43B+8.0%$2.10$3.34Release
Q2 FY2026ended Jun 30, 2026Jul 28, 2026before the open$4.37B+8.7%$1.53$3.15Release
Q1 FY2026ended Mar 31, 2026May 5, 2026before the open$4.15B+8.4%$1.61$2.90Release
Q4 FY2025ended Dec 31, 2025Feb 5, 2026before the open$4.36B+10.3%$2.99$3.42Release
Q3 FY2025ended Sep 30, 2025Oct 28, 2025before the open$4.10B+5.2%$1.93$3.00Release
Q2 FY2025ended Jun 30, 2025Jul 22, 2025before the open$4.02B+5.3%$1.54$2.81Release
Q1 FY2025ended Mar 31, 2025May 6, 2025before the open$3.83B+2.5%$1.40$2.70Release
Q4 FY2024ended Dec 31, 2024Feb 6, 2025before the open$3.96B+2.3%$2.42$3.12Release
Q3 FY2024ended Sep 30, 2024Oct 31, 2024before the open$3.90B+4.3%$1.55$2.84Release
Q2 FY2024ended Jun 30, 2024Jul 22, 2024before the open$3.81B+2.3%$1.97$2.64Release
Q1 FY2024ended Mar 31, 2024May 2, 2024before the open$3.74B+2.3%$1.56$2.54Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Iqvia's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
revenueGAAPFY2026$17.35B – $17.50B–NewOct 27, 2026
revenueFY2026$17.28B – $17.48B$17.15B – $17.35BRaisedJul 28, 2026
Adjusted EBITDAnon-GAAPFY2026$4.03B – $4.06B–NewOct 27, 2026
Adjusted EBITDAnon-GAAPFY2026$4.00B – $4.05B$3.98B – $4.03BRaisedJul 28, 2026
Adjusted Diluted Earnings per Sharenon-GAAPFY2026$12.90 – $13.00–NewOct 27, 2026
Adjusted Diluted Earnings per Sharenon-GAAPFY2026$12.80 – $13.00$12.65 – $12.95RaisedJul 28, 2026

Guidance vs results

The last range Iqvia gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Adjusted Diluted Earnings per Share$11.85 – $11.95$11.93Σ4QWithin range
FY2025Revenue$16.15B – $16.25B$16.31BΣ4QAbove range
Q4 FY2023Adjusted Diluted Earnings per Share$2.79 – $2.86$2.84Within range
Q4 FY2023Revenue$3.77B – $3.80B$3.87BAbove range
Q3 FY2023Adjusted Diluted Earnings per Share$2.39 – $2.49$2.49Within range
Q3 FY2023Revenue$3.76B – $3.81B$3.74BBelow range
Q4 FY2022Adjusted Diluted Earnings per Share$2.72 – $2.82$2.78Within range
Q4 FY2022Revenue$3.65B – $3.75B$3.74BWithin range
Q3 FY2022Adjusted Diluted Earnings per Share$2.34 – $2.42$2.48Above range
Q3 FY2022Revenue$3.52B – $3.57B$3.56BWithin range
Q2 FY2022Adjusted Diluted Earnings per Share$2.35 – $2.42$2.44Above range
Q2 FY2022Revenue$3.47B – $3.52B$3.54BAbove range

Guidance history

Every forecast Iqvia put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Oct 27, 2026Adjusted EBITDAFY2026$4.03B – $4.06BNew
Oct 27, 2026Adjusted Diluted Earnings per ShareFY2026$12.90 – $13.00New
Oct 27, 2026revenueFY2026$17.35B – $17.50BNew
Jul 28, 2026Adjusted EBITDAFY2026$4.00B – $4.05BRaised
Jul 28, 2026Adjusted Diluted Earnings per ShareFY2026$12.80 – $13.00Raised
Jul 28, 2026revenueFY2026$17.28B – $17.48BRaised
May 5, 2026Adjusted EBITDAFY2026$3.98B – $4.03BReaffirmed
May 5, 2026Adjusted Diluted Earnings per ShareFY2026$12.65 – $12.95Raised
May 5, 2026revenueFY2026$17.15B – $17.35BReaffirmed
Feb 5, 2026Adjusted EBITDAFY2026$3.98B – $4.03BNew
Feb 5, 2026Adjusted Diluted Earnings per ShareFY2026$12.55 – $12.85New
Feb 5, 2026revenueFY2026$17.15B – $17.35BNew
Oct 28, 2025Adjusted EBITDAFY2025$3.78B – $3.80BNarrowed
Oct 28, 2025Adjusted Diluted Earnings per ShareFY2025$11.85 – $11.95Narrowed
Oct 28, 2025revenueFY2025$16.15B – $16.25BNew
Jul 22, 2025Adjusted EBITDAFY2025$3.75B – $3.83BNew
Jul 22, 2025Adjusted Diluted Earnings per ShareFY2025$11.75 – $12.05New
Jul 22, 2025revenueFY2025$16.10B – $16.30BNew
May 6, 2025Adjusted EBITDAFY2025$3.77B – $3.89BReaffirmed
May 6, 2025Adjusted Diluted Earnings per ShareFY2025$11.70 – $12.10Reaffirmed

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Iqvia filed with the SEC as exhibits to Form 8-K or 6-K

  1. IQVIA Reports Third-Quarter 2026 Results
    Results
  2. IQVIA Announces Offering of Senior Notes
    News
  3. IQVIA Announces Pricing of Senior Notes
    News
  4. IQVIA Reports Second-Quarter 2026 Results
    Results
  5. IQVIA Announces Pricing of Senior Notes
    News
  6. IQVIA Announces Offering of Senior Notes
    News
  7. Kerri Joseph, IQVIA Investor Relations
    News
  8. IQVIA Reports First-Quarter 2026 Results
    Results
  9. IQVIA Reports Fourth-Quarter and Full-Year 2025 Results;
    Results
  10. Kerri Joseph, IQVIA Investor Relations ([email protected])
    Update
  11. IQVIA Reports Third-Quarter 2025 Results
    Results
  12. Kerri Joseph, IQVIA Investor Relations ([email protected])
    Update
  13. IQVIA Reports Second-Quarter 2025 Results
    Results
  14. IQVIA Announces Offering of Senior Notes
    News
  15. IQVIA Announces Pricing of Senior Notes
    News